Heart Failure 2026: Optimising Outcomes Across the Care Pathway

WEBINAR

THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY

Doors open: 06:15pm | Session starts: 07:00pm
Location: MS Teams

Event Agenda

What you'll learn

• How to spot heart failure earlier in busy primary care consultations — and avoid the diagnostic delays that still affect one in three patients.
• When and how to use NT-proBNP, how to interpret borderline results, and how to navigate rapid-access referral pathways with confidence.
• The practical differences between HFrEF, HFmrEF and HFpEF — and why phenotype should shape your management plan.
• How to confidently initiate and titrate the four pillars of guideline-directed medical therapy: ARNI/ACEi/ARBs, beta-blockers, MRAs and SGLT2 inhibitors.
• How to manage common barriers to optimisation — side effects, renal function, blood pressure, and polypharmacy in frail or multimorbid patients.
• The latest evidence on HFpEF and what it means for day-to-day prescribing decisions.
• How to recognise red flags for decompensation and know exactly when to escalate, admit, or refer for advanced therapies.
• How to build a structured annual heart failure review into your practice — including medicines optimisation, lifestyle support and self-management.
• How to work more effectively across the multidisciplinary team: primary care, community heart failure nurses, pharmacy and secondary care.
• Real-world insights from Professor Fuat's own practice, through anonymised case studies and a live Q&A.

Who should attend

This webinar is designed for UK primary care and community healthcare professionals involved in the diagnosis, treatment and long-term management of heart failure, including:

• GPs and GP Registrars
• Practice Nurses and Advanced Nurse Practitioners
• Community and Specialist Heart Failure Nurses
• Primary Care Pharmacists and PCN Clinical Pharmacists
• Community Pharmacists with a clinical role
• Paramedics and Physician Associates working in primary care
• Practice Managers and clinical leads shaping long-term condition pathways

Whether you're newly qualified and building confidence with heart failure management, or an experienced clinician wanting a practical refresh on the latest guideline-directed therapy, this session will give you clear, usable takeaways for your next clinic.

Meet the Speaker

Professor Ahmet Fuat

PhD, FRCGP, FRCP, FRCPE ,FESC, FPCCS, PGDiP Cardiology

Professor Ahmet Fuat was a GP in Darlington, County Durham for 40 years, where he was CVD and Research Leads for Darlington Primary Care Network and Darlington GP Federation. He was Oberoi Consulting Medical Director from September 2023 to February 2026, is National Programme Director at Clinilink Ltd and has also worked as an Honorary Consultant Lipidologist/GPSI within the diabetes and endocrinology team at County Durham and Darlington Foundation Trust, running a secondary prevention and genetic lipid clinic. He has been a GPSI Cardiology for over 25 years having undertaken a Postgraduate Diploma in Cardiology at Bradford University graduating with distinction. He went on to be a tutor on the course for many years teaching on HF, HVD, AF and IHD. He started the first one stop diagnostic and integrated heart failure clinic in the UK in 2002 with local colleagues.His PhD by research in heart failure diagnosis and management including work on natriuretic peptides generated several publications that have informed guidelines and led to the award of an Honorary Professorial Chair at Durham University. He has contributed to various NICE and ESC CVD and HF guidelines, and RCGP CKD/AKI toolkit. He has a passion for medical education and remains an active lecturer, tutor and researcher. He is on the editorial boards of the British Journal of Cardiology and Primary Care Cardiovascular Journals and a peer reviewer for most high impact Cardiovascular journals and research bodies. His work in community cardiology has been recognised with Fellowships from the RCGP, RCP London and RCP Edinburgh, ESC and the PCCS.He has led many quality improvement initiatives over the years in HF, AF, Lipids, hypertension, diabetes and CKD. His work on HF was included in their BHF blueprint for HF. Much of this work was carried out using Oberoi digital audit platforms as has been replicated by colleagues across the UK, benefiting patients and practices positively.